Global orthopedic sales totaled $59 billion in 2023, an increase of 6.5% compared to 2022. Read our regularly updated analysis of the orthopedic market, including sales forecasts for all segments, company revenue and insight into key trends.
The Numbers
According to our estimates, just under 50 companies accounted for more than 85% of all orthopedic revenue in 2023.
Funding announcements came from familiar names and supported well-backed markets like spine and enabling technology.
April 2, 2024
,
Julie A. Vetalice
While Orthofix’s trauma business is growing slower than the market, it has an enormous opportunity in the U.S.
March 18, 2024
,
Stay up to date on the orthopedic market’s 4Q performance in 2023 as we update this post with company sales data and industry developments.
March 18, 2024
,
The company grew in the low double-digits in 2023 but a strategic review revealed Anika’s need to focus on the greatest growth opportunities.
March 15, 2024
,
The company grew in the mid-teens in 2023 with significant growth across product segments and most regions.
March 14, 2024
,
The company turned in a strong fourth quarter to push 2023 orthopedic sales growth into the low-single-digits.
March 14, 2024
,
According to our estimates, just under 50 companies accounted for more than 85% of all orthopedic revenue in 2023.
April 10, 2024
,
Funds will support commercial expansion and clinical activities for the Bridge-Enhanced ACL Restoration (BEAR) Implant.
April 2, 2024
,
Funding announcements came from familiar names and supported well-backed markets like spine and enabling technology.
March 27, 2024
,
Proceeds will accelerate aprevo personalized lumbar and cervical patient-specific interbody fusion devices.
March 18, 2024
,
While Orthofix’s trauma business is growing slower than the market, it has an enormous opportunity in the U.S.
March 18, 2024
,
Stay up to date on the orthopedic market’s 4Q performance in 2023 as we update this post with company sales data and industry developments.
March 18, 2024
,
The company grew in the low double-digits in 2023 but a strategic review revealed Anika’s need to focus on the greatest growth opportunities.
March 15, 2024
,
The company grew in the mid-teens in 2023 with significant growth across product segments and most regions.
March 14, 2024
,
The company turned in a strong fourth quarter to push 2023 orthopedic sales growth into the low-single-digits.
March 14, 2024
,
The company grew in the high teens for 2023, driven by its personalized solutions and strength across geographic regions.
